An announcement from Fujimori Kogyo Co ( ($JP:7917) ) is now available.
ZACROS Corporation has entered a strategic business alliance with TAUNS Laboratories, a leader in rapid diagnostic test kits in Japan, to develop components for next-generation Point of Care Testing (POCT) devices. This partnership is set to enhance the functionality and application range of TAUNS’s POCT devices, while leveraging ZACROS’s biochip technology to innovate global diagnostic products. Although the alliance currently has no immediate financial impact, it promises to advance medical testing convenience and efficiency, benefiting both companies and potentially reshaping the POCT market.
More about Fujimori Kogyo Co
ZACROS Corporation, formerly known as Fujimori Kogyo Co., Ltd., is a Tokyo-based company with a long history in the pharmaceutical and medical packaging industry. They specialize in film processing technology and have expanded into the intersection of plastics and biotechnology, offering products like BioPhaS for biopharmaceutical manufacturing and medical devices like the T-TAS system. The company has been in operation since 1914 and has diversified into various fields including packaging materials for daily necessities, contract cell culture services, and electronic materials.
YTD Price Performance: -6.92%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €469.3M
Learn more about 7917 stock on TipRanks’ Stock Analysis page.
